Kyle Jones

Pall Biotech

Kyle Jones is R&D applications scientist II at Pall Biotech.

Articles

Assessing Viral Inactivation for Continuous Processing

Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.